Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedAdded the term 'Small cell lung carcinoma' to the listed conditions and included a 'Genetic and Rare Diseases Information Center' resource entry.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated to v3.4.2; the previous government funding notices and the v3.4.1 revision text were removed. No study data or eligibility information appears affected.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, and updated the site version to v3.4.1 with removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a glossary display option and updated footer metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; removed the lowercase variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.